BLOG

Planning NK Cell Therapy in Osaka as an International Patient: What to Confirm First

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

For many people living outside Japan, the idea of receiving cancer immune cell therapy in another country raises practical questions long before any medical ones. How many visits are needed? What should be confirmed before booking flights? Who will coordinate with the doctor who is already treating you? This article offers a framework for thinking through these questions if you are considering NK cell therapy at Grand Green Osaka Umekita Clinic in Osaka, Japan.

Start with the medical question, not the travel plan

It is tempting to begin with dates, flights and hotels. In practice, the more useful order is the reverse. NK (natural killer) cell therapy is an immune cell therapy in which your own NK cells are collected from a standard blood draw, activated and expanded at a specialized facility, and then returned to your body by intravenous infusion. Whether this approach is appropriate for you depends on your diagnosis, your current treatment, and your overall health. Those are questions for a physician, not for a travel itinerary.

NK cells are innate immune cells that patrol the body and can recognize and attack abnormal cells, including cancer cells and virus-infected cells. NK cell activity is known to decline with age, stress and the effects of cancer itself, and the therapy aims to return a larger number of more active NK cells. It is important to understand that this is a treatment option to learn about and discuss, not a promise of a particular outcome. Responses differ from person to person, and the therapy is not a replacement for standard cancer care.

Talk with your current oncologist early

If you are already receiving surgery, chemotherapy or radiation therapy, your own care team knows your situation best. Letting them know that you are exploring NK cell therapy in Japan is a sensible first step. The therapy is described as something that can be considered alongside standard treatment, and Grand Green Osaka Umekita Clinic notes that it can coordinate with the medical institution providing your standard care. Even so, the timing of any immune cell therapy relative to your other treatments should be decided together with your doctors.

It can help to bring a short written summary to that conversation, including your diagnosis, the treatments you have had, the medicines you currently take, and recent test results. A clear summary makes it easier for every physician involved to give you useful advice, and it reduces the risk of misunderstandings across languages and health systems.

Understand what the treatment process involves

The basic flow of NK cell therapy has several stages: a consultation, a blood draw, culture and expansion of the cells at a licensed cell processing facility, and then infusion of the cells. Because the cells are prepared from your own blood and need time to be cultured, the process does not happen in a single day. This matters for international patients, because the schedule of blood draws and infusions affects how long you may need to be in Japan or how often you may need to return.

The therapy is delivered on an outpatient basis, meaning it does not require hospitalization. Treatment involves a standard blood draw and an intravenous infusion. Even so, the exact number of visits, the interval between them and the overall duration are matters to be confirmed with the physician at your consultation, because they can depend on individual circumstances. Please avoid planning non-refundable travel until you have received a clear explanation of the proposed schedule.

Ask about safety, regulation and possible side effects

In Japan, cell therapies of this kind are provided under a regenerative medicine framework, the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be submitted to and accepted by the authorities and requires cells to be handled at appropriate facilities. This framework is one reason it is reasonable to ask any clinic to explain which plan covers the therapy being offered and how cells are processed and tracked. Patients from abroad may find that the rules in their home country differ, so it is worth asking directly rather than assuming.

Because the therapy uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. That said, temporary fever or fatigue may occur, and no medical treatment is free of risk. Questions worth asking include what reactions to expect after an infusion, how they are monitored, what you should do if symptoms appear after you have returned home, and which hospital or doctor can help you in your own country if needed.

Clarify costs, eligibility and limits before you commit

NK cell therapy at Grand Green Osaka Umekita Clinic is a self-pay treatment, which means it is not covered by public health insurance in Japan. Your overseas insurer may not cover it either. For that reason, please ask for an explanation of the fees, what they include and what they do not include, and read the clinic’s fee information carefully before making a decision. Eligibility is also determined by a doctor after an examination, so not everyone who is interested will necessarily be a suitable candidate.

It is equally important to be realistic about limits. NK cell therapy is not guaranteed to work, it is not a substitute for surgery, chemotherapy or radiation, and the evidence base for immune cell therapies continues to develop. A trustworthy consultation should discuss these limits openly. If an explanation sounds like a promise of a cure, that is a reason to ask more questions.

Use multilingual support to prepare for a consultation

Grand Green Osaka Umekita Clinic is located in Umeda, Osaka, an area that is easy to reach by train, and it offers an information page for international patients in multiple languages. Reading the information in your own language beforehand, and writing down your questions, can make a first consultation far more productive. You may also wish to ask in advance whether interpretation support is available for the consultation itself.

  • A summary of your diagnosis, past treatments and current medicines.
  • Questions about the proposed schedule, number of visits and length of stay.
  • Questions about safety, expected reactions and follow-up after you return home.
  • Questions about fees, what is included and what is not.
  • Your own oncologist’s view on timing alongside standard treatment.

Summary

Planning NK cell therapy in Osaka as an international patient is best approached in stages: first the medical question, then a conversation with your current doctors, then a consultation to confirm the process, safety framework, costs and limits, and only afterward the travel arrangements. NK cell therapy is a self-pay option provided in Japan under a regenerative medicine framework, and its suitability, risks, side effects and cost must be confirmed through an examination and consultation with a physician. If you would like to learn more, you can review the NK cell therapy information page of Grand Green Osaka Umekita Clinic and then contact the clinic to arrange a consultation.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact